Comphya SA

First neurostimulator to treat erectile dysfunction

Swiss Startup - Comphya Additional Image

We are developing an active implantable medical device, named CaverSTIM, to restore the erectile function of post-prostatectomy patients or others non-responsive to oral drugs (e.g. Viagra or Cialis). To achieve erection, these patients resort to intrapenial injections of vasodilators or penile implants, which are quite problematic and outdated, but the only option for a large population (approx. 1B existing market). CaverSTIM offers a far better therapeutic modality for an under-addressed market.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

28.01.2026

New studies validate Aesyra and Comphya devices (startupticker.ch)

15.10.2025

Swiss medtechs report clinical progress in heart, brain, and rrological health (startupticker.ch)

15.10.2025

Swiss medtechs report clinical progress in heart, brain, and urological health (startupticker.ch)

09.07.2025

Comphya closes CHF 7.5M Series A to advance erectile dysfunction therapy (venturelab.swiss)

09.07.2025

Additional funding brings Comphya’s series A to CHF 7.5 million (startupticker.ch)

25.02.2025

Comphya secures CHF 4.35M in Series A first tranche to support CaverSTIM clinical trials (venturelab.swiss)

24.02.2025

Comphya secures Series A First Tranche of CHF 4.35M (startupticker.ch)

07.01.2025

Comphya receives FDA IDE approval to initiate clinical trials in the US (startupticker.ch)

29.11.2023

Swiss medtech startups enter next development phase (startupticker.ch)

23.08.2023

World first medical device implantation to restore erectile function (startupticker.ch)

10.07.2023

Comphya launches clinical study with spinal chord injury patients (startupticker.ch)

13.03.2023

Comphya receives approval for first long-term implantation clinical trial (startupticker.ch)

31.01.2023

Comphya raises funds for clinical trials (startupticker.ch)

09.05.2022

Startup internationalisation camp in the US in progress (startupticker.ch)

06.12.2021

Tech tour presents 12 winners from Switzerland (startupticker.ch)

14.10.2021

Alpine Techstars to attract investors (startupticker.ch)

02.12.2020

Comphya raises additional USD 1.3 million (startupticker.ch)

01.12.2020

Comphya raises CHF 1.3M for clinical trials execution (venturelab.swiss)

18.02.2020

10 Swiss Medtech Startups to Watch in 2020 (venturelab.swiss)

16.12.2019

IMD Startup competition reveals the winners of the 2019/2020 edition (startupticker.ch)

10.08.2023

Start of 2 Pilot Clinical Trials

30.04.2020

Partnership for product development

30.11.2018

Publication of Proof of Concept results

No Jobs

No videos and documents

TOP 100 Swiss Startup Award

The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.

TOP 100 Swiss Startups 2018

Website

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Venture Kick (30'000) 2017

Website

EPFL Spin-Off

EPFL Spin-off 2017

Website

Venture Leaders Life Sciences

The venture leaders - the members of the Swiss national startup team- have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The ten-day business development program is specifically structured to help them achieve this goal.

Venture Leaders Life Sciences 2017

Website